
Novo Nordisk Seeks Injunction Against Eli Lilly Weight-Loss Drug Ads
Novo Nordisk has filed for a preliminary injunction to block Eli Lilly's advertisements for its weight-loss drug. Novo Nordisk is pursuing legal action to prevent the competitor's marketing campaign.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (47/100)Sources
Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads
Denmark's Novo Nordisk said on Tuesday that it had sued Lilly, arguing consumers were being misled about how the companies' products compare.
Read full article →


